Breaking News

Lonza to Build Large-Scale Commercial Fill/Finish Facility in Stein

To provide customers with an integrated end-to-end solution that includes commercial drug product manufacturing for large-scale market supply.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza is investing approximately CHF 500 million to construct a large-scale commercial drug product fill and finish facility in Stein (CH). The investment will enable the company to provide customers with an integrated end-to-end solution that includes commercial drug product manufacturing for large-scale market supply. The new facility is expected to be completed in 2026.   Pierre-Alain Ruffieux, CEO, Lonza, said, “This strategic investment completes our offering in drug product and strengthe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters